New Nanoparticle Antitumor Vaccines Control Melanoma Growth in Preclinical Models
Azonano,
At the Wistar Institute, researchers merged synthetic DNA technology with their expertise in protein engineering to…
At the Wistar Institute, researchers merged synthetic DNA technology with their expertise in protein engineering to…
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully…
Synthetic DNA nanovaccines enhance killer T cell immunity resulting in tumor control in preclinical studies Researchers…
L-R: Wistar scientists Drs. David Weiner
Newswise — PHILADELPHIA — (Sept. 10, 2020) — Combining their expertise in protein engineering and synthetic DNA technology…
( Nanowerk News ) Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar…
Post Views: 1 PHILADELPHIA (Sept. 10, 2020) Combining their expertise in protein engineering and synthetic DNA technology…
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and…